glutathione disulfide has been researched along with candesartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cachofeiro, V; Cediel, E; de las Heras, N; González Pacheco, FR; Jiménez, J; Lahera, V; Oubina, MP; Sanz-Rosa, D; Vegazo, O | 1 |
| Fischer, K; Kairane, C; Kampus, P; Muda, P; Ristimäe, T; Teesalu, R; Zilmer, K; Zilmer, M | 1 |
1 trial(s) available for glutathione disulfide and candesartan
| Article | Year |
|---|---|
Effect of antihypertensive treatment with candesartan or amlodipine on glutathione and its redox status, homocysteine and vitamin concentrations in patients with essential hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Folic Acid; Glutathione; Glutathione Disulfide; Homocysteine; Humans; Hypertension; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Tetrazoles; Vitamin B 12 | 2005 |
1 other study(ies) available for glutathione disulfide and candesartan
| Article | Year |
|---|---|
Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Glutathione Reductase; Hypertension; Liver; Malondialdehyde; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Oxidative Stress; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tetrazoles | 2003 |